LD-2 disclosure · 1st Quarter - Report
PARKINSON'S ACTION NETWORK
Client
- Location
- District of Columbia · United States of America
Registrant
- Description
- Medical/Disease Research/Clinical Labs
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesMedicare/Medicaid
Medicare Part D entitlement reform proposals
LobbyistsCATHERINE PUGH · ms REBECCA W O'CONNOR · JENNIFER SHERIDAN PALUTE
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)
Medical/Disease Research/Clinical Labs
P.L. 112-25, "Budget Control Act of 2011," all sections relating to sequestration; P.L 113-006, "Consolidated and Further Continuing Appropriations Act, 2013," sections relating to the National Institutes of Health (NIH); Food and Drug Administration, and the Peer-Reviewed Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program;"Fiscal Year 2014 Department of Labor, Health and Human Services, Education and Related Agencies Appropriations," all sections relating to the National Institutes of Health (NIH); "Fiscal Year 2014 Department of Defense Appropriations,"all sections relating to the Peer-Reviewed Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Fiscal Year 2014 Department of Agriculture, Rural Development, Food and Drug Adminstration, and Related Agencies Appropriations," all sections relating to the Food and Drug Administration.
LobbyistsCATHERINE PUGH · ms REBECCA W O'CONNOR · JENNIFER SHERIDAN PALUTE
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)
Health Issues
